Atypical Antipsychotics Summary by CEUfast, Inc.

Atypical Antipsychotics is organized by CEUfast, Inc.. This course has been approved for a maximum of 2 Contact Hours including 2 Advanced Pharmacology Hours.

Last Updated: 11/7/2023
This course will be updated or discontinued on or before Monday, May 31, 2027

Outcomes:
92% of participants will be able to identify the uses, forms, and possible adverse effects of atypical antipsychotic medications.

Objectives:
After completing this continuing education course, the participant will be able to:

• Describe the labeled uses of atypical antipsychotics.
• Analyze the adverse effects that can result from taking atypical antipsychotics.
• Identify the rationale for utilizing long-acting injectable forms of atypical antipsychotics.
• Describe the body’s reaction to abrupt discontinuation of atypical antipsychotics.
• Explain the monitoring that must be considered when caring for a patient prescribed atypical antipsychotics.